Machine learning based early warning system enables accurate mortality risk prediction for COVID-19
暂无分享,去创建一个
Ding Ma | Yang Yu | Lingxi Chen | Xun Tian | D. Ma | Wei Fang | Q. Gao | F. Ye | Lin Li | Yue Gao | Guang-Yao Cai | Wei Fang | Hua-Yi Li | Si-Yuan Wang | Dan Liu | Sen Xu | Peng-Fei Cui | Shao-Qing Zeng | Xin-Xia Feng | Rui-Di Yu | Ya Wang | Yuan Yuan | Xiao-Fei Jiao | Jian-Hua Chi | Jia-Hao Liu | Ru-Yuan Li | Xu Zheng | Chun-Yan Song | Ning Jin | Wen-Jian Gong | Xing-Yu Liu | Lei Huang | Hui Xing | Chun-Rui Li | Fei Ye | Qing-Lei Gao | Chunrui Li | Lingxi Chen | X. Tian | H. Xing | Lei-lei Huang | Lin Li | Peng-fei Cui | Ruyuan Li | Sen Xu | Dan Liu | Chunyan Song | Jiahao Liu | X. Jiao | Yang Yu | S. Zeng | J. Chi | Ruidi Yu | Xu Zheng | Ya Wang | Yue Gao | Xinxia Feng | Huayi Li | Yuan Yuan | G. Cai | Wenjian Gong | Si-yuan Wang | Ning Jin | Xingchi Liu | Xun Tian
[1] Limin Ou,et al. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. , 2020, JAMA internal medicine.
[2] J. Marrero,et al. Comparison of imputation methods for missing laboratory data in medicine , 2013, BMJ Open.
[3] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[4] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[5] P. Lambin,et al. Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: an International Multicenter Study , 2020, medRxiv.
[6] D. Morrow,et al. COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery , 2020, Journal of the American College of Cardiology.
[7] Raymond Y Huang,et al. AI Augmentation of Radiologist Performance in Distinguishing COVID-19 from Pneumonia of Other Etiology on Chest CT , 2020, Radiology.
[8] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[9] Jeffrey Dean,et al. Machine Learning in Medicine , 2019, The New England journal of medicine.
[10] Yaling Shi,et al. A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Spiros C. Denaxas,et al. A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service , 2019, The Lancet. Digital health.
[12] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[13] S. Singh-Carlson. INTERNATIONAL PERSPECTIVE. , 2015, Canadian oncology nursing journal = Revue canadienne de nursing oncologique.
[14] D. Morrow,et al. Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective , 2020, Journal of the American College of Cardiology.
[15] Gary S Collins,et al. Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness , 2020, BMJ.
[16] B. Dai,et al. Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer , 2018, Clinical Cancer Research.
[17] M. Chua,et al. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China , 2020, JAMA oncology.
[18] Jun Yu Li,et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study , 2020, The Lancet Oncology.
[19] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[20] L. Gostin,et al. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. , 2020, JAMA.
[21] Mohammad Pourhomayoun,et al. Predicting Mortality Risk in Patients with COVID-19 Using Artificial Intelligence to Help Medical Decision-Making , 2020, medRxiv.
[22] Chuan Liu,et al. Machine learning-based CT radiomics method for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: a multicenter study. , 2020, Annals of translational medicine.
[23] Richard D Riley,et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal , 2020 .
[24] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[25] Stef van Buuren,et al. Flexible Imputation of Missing Data , 2012 .
[26] Stef van Buuren,et al. Flexible Imputation of Missing Data, Second Edition , 2018 .
[27] Z. Fayad,et al. Artificial intelligence–enabled rapid diagnosis of patients with COVID-19 , 2020, Nature Medicine.
[28] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[29] Jian Sun,et al. ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China , 2020, medRxiv.
[30] P. Lambin,et al. Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study , 2020, European Respiratory Journal.
[31] R. C. Macridis. A review , 1963 .
[32] G. Heinze,et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal , 2020, BMJ.
[33] Yu Shi,et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan , 2020, Critical Care.
[34] Peter Bühlmann,et al. MissForest - non-parametric missing value imputation for mixed-type data , 2011, Bioinform..
[35] Yaling Shi,et al. A Tool to Early Predict Severe 2019-Novel Coronavirus Pneumonia (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China , 2020, medRxiv.
[36] Zhiquan Hu,et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study , 2020, The Lancet Oncology.
[37] Haibo He,et al. Learning from Imbalanced Data , 2009, IEEE Transactions on Knowledge and Data Engineering.
[38] Yu Zhou,et al. Predicting COVID-19 malignant progression with AI techniques , 2020, medRxiv.
[39] Wen Yin,et al. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, medRxiv.
[40] Sharon J Peacock,et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.
[41] A. Cho. AI systems aim to sniff out coronavirus outbreaks. , 2020, Science.
[42] Arturo Gonzalez-Izquierdo,et al. UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER , 2019, J. Am. Medical Informatics Assoc..